Expression levels of CXCR4 and CXCL12 in patients with rheumatoid arthritis and its correlation with disease activity
Authors:
Open Access
- 26 June 2020
- journal article
- research article
- Published by Spandidos Publications in Experimental and Therapeutic Medicine
- Vol. 20 (3) , 1925-1934
Abstract
The present study aimed to investigate the expression levels of C‑X‑C motif chemokine receptor 4 (CXCR4) and CXC ligand 12 (CXCL12) in patients with rheumatoid arthritis (RA) and the correlation with disease activity. In total, 60 patients with RA were selected as the study group, comprising of 28 patients in active‑stage and 32 patients in remission‑stage. In addition, 60 patients with osteoarthritis were selected as the control group. Western blotting and ELISA were used to detect the expression of CXCR4 and CXCL12, respectively. The Spearman's correlation test was used to analyze correlations between CXCR4 and CXCL12, and erythrocyte sedimentation rate (ESR), C‑reactive protein (CRP), disease activity score 28 (DAS28) scores and rheumatoid factor (RF). The present results suggested that CXCR4 and CXCL12 expression levels in the serum and joint synovial fluid of the study group were significantly higher compared with the control group (P<0.05). Moreover, CXCR4 and CXCL12 expression levels in the RA‑active group were higher compared with the remission (P<0.05) and control groups (P<0.01). The Pearson test results suggested that the expression levels of CXCR4 and CXCL12 in the serum and joint synovial fluid of patients with RA had a positive correlation with the ESR, CRP, RF and DAS28 scores (P<0.05). CXCL12 and CXCR4 were highly expressed in the serum and joint synovial fluid of patients with RA, and these expression levels were positively correlated with ESR, CRP, RF and DAS28 scores. Therefore, these clinical parameters may be used as indicators to evaluate the disease activity of patients with RA.Keywords
This publication has 51 references indexed in Scilit:
- Attenuation of osteoarthritis via blockade of the SDF-1/CXCR4 signaling pathwayArthritis Research & Therapy, 2012
- DNA methylation regulates the expression of CXCL12 in rheumatoid arthritis synovial fibroblastsGenes & Immunity, 2011
- CXC chemokine receptor 4 expressed in T cells plays an important role in the development of collagen-induced arthritisArthritis Research & Therapy, 2010
- Dysregulated expression of CXCR4/CXCL12 in subsets of patients with systemic lupus erythematosusArthritis & Rheumatism, 2010
- DNA hypomethylation in rheumatoid arthritis synovial fibroblastsArthritis & Rheumatism, 2009
- Chemokine receptor expression and functional effects of chemokines on B cells: implication in the pathogenesis of rheumatoid arthritisArthritis Research & Therapy, 2009
- Targeted Disruption of the CXCL12/CXCR4 Axis Inhibits Osteolysis in a Murine Model of Myeloma-Associated Bone LossJournal of Bone and Mineral Research, 2009
- Rituximab does not compromise the mobilization and engraftment of autologous peripheral blood stem cells in diffuse-large B-cell lymphomaBone Marrow Transplantation, 2007
- Increase of interferon‐γ‐inducible CXC chemokine CXCL10 serum levels in patients with active Graves’ disease, and modulation by methimazole therapyClinical Endocrinology, 2006
- Grafting of Fibroblasts Isolated from the Synovial Membrane of Rheumatoid Arthritis (RA) Patients Induces Chronic Arthritis in SCID Mice—A Novel Model for Studying the Arthritogenic Role of RA FibroblastsJournal of Autoimmunity, 2000